English to Swedish Medical Medical: Instruments Clinical Trial

Primary Endpoint:
In-segment Late Loss at 120 days (Group A), at 180 days (Group B) and at 1 year (Group C).
Sen minsking i segment efter 120 ....??
även:
In-stent Late Loss at 120 days (Grupp A), 180 days (Grupp B), 1 year (Grupp C)
In-stent and in-segment Angiographic Binary Restenosis (ABR) rate at 120 days (Grupp A), 180 days (Grupp B) and 1 year (Grupp C)